A study of the β + /EC decay of 110 In into levels of 110 Cd is combined with a reanalysis of data from a previous study of 110 Cd with the (n, n ′ γ) reaction with monoenergetic neutrons. The γγ coincidences from the 110 In decay leads to many new assignments of γ rays observed in the (n, n ′ γ) reaction, permitting the observation of weak low-energy transitions, and setting stringent upper limits on unobserved decay branches. The uncertainties on many of the lifetimes from the (n, n ′ γ) reaction are significantly reduced, and limits are established for the lifetimes of levels too long for a direct measurement. The absence of enhanced transitions between the previously assigned phonon states and the deformed intruder states strongly suggests that mixing between the configurations is generally weak, refuting the strong-mixing scenario as an explanation of the decay pattern of the excited 0 + states in 110 Cd. The decay pattern of the non-intruder states is suggestive of a γ-soft rotor, or O(6) nucleus, rather than a vibrational, or U (5) pattern. The existence of a 4p − 6h proton excitation in 110 Cd is also suggested.
From detailed spectroscopy of 110 Cd and 112 Cd following the β + /EC decay of 110,112 In and the β − decay of 112 Ag, the presence of very weak decay branches from non-yrast states is revealed. In pattern suggesting that they are built on multiparticle-multihole proton excitations. The results are compared with beyond-mean-field calculations that reproduce qualitatively the observed levels and their decays, and suggest that the 0 + 1 , 0 + 2 , 0 + 3 , and 0 + 4 levels, and the excited states built on them, possess different deformations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.